160 related articles for article (PubMed ID: 9126221)
1. Prostate-specific antigen. Its discovery and biochemical characteristics.
Sokoll LJ; Chan DW
Urol Clin North Am; 1997 May; 24(2):253-9. PubMed ID: 9126221
[TBL] [Abstract][Full Text] [Related]
2. Serum concentrations of prostate-specific antigen measured using immune extraction, trypsin digestion, and tandem mass spectrometry quantification of LSEPAELTDAVK peptide.
Klee EW; Bondar OP; Goodmanson MK; Trushin SA; Bergstralh EJ; Singh RJ; Anderson NL; Klee GG
Arch Pathol Lab Med; 2014 Oct; 138(10):1381-6. PubMed ID: 25268201
[TBL] [Abstract][Full Text] [Related]
3. PSA and other tissue kallikreins for prostate cancer detection.
Stephan C; Jung K; Lein M; Diamandis EP
Eur J Cancer; 2007 Sep; 43(13):1918-26. PubMed ID: 17689069
[TBL] [Abstract][Full Text] [Related]
4. Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: a glycopeptide approach.
Tajiri M; Ohyama C; Wada Y
Glycobiology; 2008 Jan; 18(1):2-8. PubMed ID: 17956937
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen: current status.
Lukes M; Urban M; Záleský M; Zachoval R; Herácek J; Zdárský E
Folia Biol (Praha); 2001; 47(2):41-9. PubMed ID: 11321246
[TBL] [Abstract][Full Text] [Related]
6. Serum pro prostate specific antigen improves cancer detection compared to free and complexed prostate specific antigen in men with prostate specific antigen 2 to 4 ng/ml.
Catalona WJ; Bartsch G; Rittenhouse HG; Evans CL; Linton HJ; Amirkhan A; Horninger W; Klocker H; Mikolajczyk SD
J Urol; 2003 Dec; 170(6 Pt 1):2181-5. PubMed ID: 14634374
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen: current status.
Brawer MK
CA Cancer J Clin; 1999; 49(5):264-81. PubMed ID: 11198954
[TBL] [Abstract][Full Text] [Related]
8. Percent free prostate-specific antigen: entering a new era in the detection of prostate cancer.
Vashi AR; Oesterling JE
Mayo Clin Proc; 1997 Apr; 72(4):337-44. PubMed ID: 9121181
[TBL] [Abstract][Full Text] [Related]
9. [Molecular forms of prostate-specific antigen and their clinical significance].
Hilz H
Urologe A; 1995 Jul; 34(4):275-82. PubMed ID: 7545841
[TBL] [Abstract][Full Text] [Related]
10. Proenzyme forms of prostate-specific antigen in serum improve the detection of prostate cancer.
Mikolajczyk SD; Catalona WJ; Evans CL; Linton HJ; Millar LS; Marker KM; Katir D; Amirkhan A; Rittenhouse HG
Clin Chem; 2004 Jun; 50(6):1017-25. PubMed ID: 15054080
[TBL] [Abstract][Full Text] [Related]
11. The discovery of prostate-specific antigen.
Rao AR; Motiwala HG; Karim OM
BJU Int; 2008 Jan; 101(1):5-10. PubMed ID: 17760888
[TBL] [Abstract][Full Text] [Related]
12. Prostate specific antigen. Current clinical application and future prospects.
Duskova K; Vesely S
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Mar; 159(1):18-26. PubMed ID: 25277491
[TBL] [Abstract][Full Text] [Related]
13. Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios.
Oesterling JE; Jacobsen SJ; Klee GG; Pettersson K; Piironen T; Abrahamsson PA; Stenman UH; Dowell B; Lövgren T; Lilja H
J Urol; 1995 Sep; 154(3):1090-5. PubMed ID: 7543605
[TBL] [Abstract][Full Text] [Related]
14. Individual prostate-specific antigen (PSA) forms as prostate tumor markers.
Becker C; Lilja H
Clin Chim Acta; 1997 Jan; 257(1):117-32. PubMed ID: 9028629
[TBL] [Abstract][Full Text] [Related]
15. [Prostate-specific antigen: an evaluation 15 years after its discovery].
Janssen T; Schulman C
Prog Urol; 1994 Apr; 4(2):171-80. PubMed ID: 7515305
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen and prostate cancer.
Rosalki SB; Rutherford FJ
Int J Clin Pract; 2000 Nov; 54(9):611-3. PubMed ID: 11220990
[TBL] [Abstract][Full Text] [Related]
17. Significance of different molecular forms of serum PSA. The free, noncomplexed form of PSA versus that complexed to alpha 1-antichymotrypsin.
Lilja H
Urol Clin North Am; 1993 Nov; 20(4):681-6. PubMed ID: 7505976
[TBL] [Abstract][Full Text] [Related]
18. [Tumor markers in prostate cancer--clinical significance and future prospect of prostate specific antigen (PSA)].
Tsuchiya N; Ohyama C; Habuchi T
Gan To Kagaku Ryoho; 2005 Feb; 32(2):275-80. PubMed ID: 15751649
[TBL] [Abstract][Full Text] [Related]
19. Free and complexed prostate specific antigen in the differentiation of benign prostatic hyperplasia and prostate cancer: studies in serum and plasma samples.
España F; Royo M; Martínez M; Enguídanos MJ; Vera CD; Estellés A; Aznar J; Jiménez-Cruz JF; Heeb MJ
J Urol; 1998 Dec; 160(6 Pt 1):2081-8. PubMed ID: 9817329
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer.
Okihara K; Cheli CD; Partin AW; Fritche HA; Chan DW; Sokoll LJ; Brawer MK; Schwartz MK; Vessella RL; Loughlin KR; Johnston DA; Babaian RJ
J Urol; 2002 May; 167(5):2017-23; discussion 2023-4. PubMed ID: 11956430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
